Insider Trading & Executive Data
Start Free Trial
60 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
TruBridge, Inc. is a healthcare technology and services provider serving primarily small community hospitals and related health systems through two segments: Financial Health (RCM, managed IT, consulting, analytics) and Patient Care (EHR software, cloud EHR, patient engagement). In 2024 TruBridge generated $342.6M of revenue, with Financial Health ~63% of revenue and a twelve‑month recurring support/RCM backlog in the low‑to‑300s of millions (~$322–328M), reflecting a heavy mix of recurring subscription and services fees. Management is intentionally shifting toward SaaS/recurring revenue (now dominant for new installs), pursuing cross‑sell of RCM into its EHR base, margin optimization (offshoring, automation) and selective M&A while managing material exposure to Medicare/Medicaid reimbursement, HIPAA/state privacy rules and debt maturities. Recent financial improvement includes narrowing net losses in 2024 and a swing to quarterly profitability in 2025, but the company carries meaningful leverage and ongoing execution risks around SaaS conversion and client migrations.
Given TruBridge’s business mix and management commentary, incentive plans are likely weighted toward recurring‑revenue and margin metrics rather than one‑time installation revenue; sensible performance levers include ARR/recurring revenue growth, customer retention/churn (LTM retention ~94.5% noted), cross‑sell bookings, adjusted EBITDA and operating cash flow. Long‑term equity (RSUs/PSUs and options) will commonly be used to align executives with multi‑year SaaS migration and product development goals (TruBridge capitalized ~$17.1M of application development in 2024 and spent ~$34.5M on product development), and performance vesting could tie to recurring backlog/ARR or EBITDA targets to discourage short‑term revenue recognition games. Because management emphasizes margin optimization and debt reduction, compensation may also include leverage or cash‑flow targets and special retention or earn‑out arrangements related to acquisitions (e.g., Viewgol) and divestitures (AHT sale). Regulatory/compliance risk (HIPAA, payer rules) and potential material accounting judgments (ASC 606 allocation, impairment triggers) make clawback provisions, compliance/KPI gating and disclosure controls likely features of executive pay.
Insiders at TruBridge are subject to standard Section 16 reporting (Form 4 within required window), and given the company’s small‑market profile and leverage exposure, it is common to see 10b5‑1 trading plans used to time diversification while avoiding selective‑information risk. Material cadence drivers to watch for insider activity include quarterly earnings, large RCM/EHR contract wins or losses, SaaS migration announcements, M&A or financing events (debt maturities and revolver availability are recurring liquidity focal points), and regulatory or reimbursement changes affecting customer spend. Because recurring backlog and retention drive long‑term value, insider purchases can be a stronger positive signal than opportunistic insider sales, which may instead reflect personal diversification needs or anticipated dilution/financing; also expect company blackout windows around earnings and sensitive implementation or contract negotiations and potential trading restrictions tied to compliance incidents.